Insider Trading Activity For PURE Bioscience (OTCMKTS:PURE)
Tom Y. Lee , Director of PURE Bioscience (OTCMKTS:PURE) reportedly Sold 14,885 shares of the company’s stock at an average price of 0.95 for a total transaction amount of $14,140.75 SEC Form
Insider Trading History For PURE Bioscience (OTCMKTS:PURE)
Analyst Ratings For PURE Bioscience (OTCMKTS:PURE)
These are No ratings tracked in the last 12 months.The current consensus rating for PURE Bioscience (OTCMKTS:PURE) is N/A (Score: NaN) with a consensus target price of N/A
About PURE Bioscience (OTCMKTS:PURE)
Pure Bioscience, Inc. is focused on developing and commercializing antimicrobial products primarily in the food safety arena that provide solutions to the health and environmental challenges of pathogen and hygienic control. The Company’s technology platform is based on patented stabilized ionic silver, and initial products contain silver dihydrogen citrate (SDC). SDC is manufactured as a liquid delivered in various concentrations. The Company currently manufactures and distributes SDC-based disinfecting and sanitizing products, which are registered by the Environmental Protection Agency (EPA).
Recent Trading Activity for PURE Bioscience (OTCMKTS:PURE)
Shares of PURE Bioscience closed the previous trading session at 0.940 0.000 0.00% with shares trading hands.